Fourier-domain OCT gives consistent results for flap-thickness measurements

Article

A recent study published in the Journal of Cataract and Refractive Surgery has established that Fourier-domain optical coherence tomography (OCT) gives the highly repeatable flap-thickness measurements.

A recent study published in the Journal of Cataract and Refractive Surgery has established that Fourier-domain optical coherence tomography (OCT) gives the highly repeatable flap-thickness measurements.

A team led by Dr Yan Li, Doheny Eye Institute, University of Southern California, Los Angeles, California, USA, conducted a case series evaluation of the repeatability of Fourier-domain OCT on 21 patients. One week after LASIK, Fourier-domain OCT was used to measure flap thickness at 6 positions over the corneal flap. Pooled standard deviations (SDs) were used to calculate within-grade flap thickness repeatability and between-grader reproducibility.

The results demonstrated that the mean flap thickness measurements were highly predictable on all points on the corneal flap. The within-grader repeatability was recorded at 3.3 to 6.4 μm for the same image measured at various times and 4.7 to 7.4 μm for different images. Thickness SDs ranged from 5.3 to 9.5 μm and uniformity varied from 121.7 to 126.5 μm. The between-grader reproducibility ranged from 4.0 to 9.0 μm.

It was concluded LASIK flaps created by femtosecond laser had a consistent and predictable thickness. Asymmetry between the nasal side and the temporal side, the superior side and the inferior side and the pericentral area and the central point of the corneal flap wasn't statistically significant.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.